Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT-2 inhibitors and GLP-1 receptor agonists

A. Bonaventura, S. Carbone, D. L. Dixon, A. Abbate, F. Montecucco

Research output: Contribution to journalReview article

Fingerprint Dive into the research topics of 'Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT-2 inhibitors and GLP-1 receptor agonists'. Together they form a unique fingerprint.

Medicine & Life Sciences